论文部分内容阅读
1973至1988年期间美国较年轻的妇女卵巢癌死亡率下降25％,但65岁以上妇女卵巢癌死亡率增加16％。为了更好地总结治疗老年妇女卵巢癌的经验,作者分析了1974至1988年收治的3期卵巢癌系统化疗的结果。将卵巢癌病人按治疗时间顺序分为三组:一组(1974至1978年):环磷酰胺1000mg/m~2或环磷酰胺500mg/m~2+阿霉素40mg/m~2。二组(1980至1984年):环磷酰胺1000mg/m~2+顺铂60mg/m~2或六甲
Older women in the United States experienced a 25% decrease in ovarian cancer mortality between 1973 and 1988, but a 16% increase in ovarian cancer mortality among women over the age of 65. In order to better summarize the experience of treatment of ovarian cancer in elderly women, the authors analyzed the results of three stage ovarian cancer chemotherapy admitted from 1974 to 1988. The ovarian cancer patients were divided into three groups according to the treatment time sequence: one group (1974-1978): cyclophosphamide 1000mg / m ~ 2 or cyclophosphamide 500mg / m ~ 2 + doxorubicin 40mg / m ~ 2. Two groups (1980 to 1984): cyclophosphamide 1000mg / m ~ 2 cisplatin 60mg / m ~ 2 or Liujia